Palvella Therapeutics, Inc (PVLA)

Palvella Therapeutics, Inc (PVLA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.7B; returns 1 day -1.0%, 1 week +4.0%, 1 year +75.5%.

Palvella Therapeutics, Inc. (PVLA) is a clinical-stage biopharmaceutical company focused on developing topical therapies for rare and debilitating skin diseases with significant unmet medical needs.

Groups PVLA belongs to

• Biotechnology
• Clinical Stage Biotech
• Rare Diseases
• Dermatology
• Lymphatic Malformations
• Healthcare
• Biopharmaceutical
• Clinical Stage
• Unmet Medical Needs
• Life Sciences

PVLA financial model: income statement, cash flow and balance sheet